Source: World Health Organization (WHO) |

WHO and the International Organisation of the Francophonie (IOF) sign Memorandum of Understanding to strengthen access to health in Francophone countries

Promoting COVID-19 vaccine equity, fighting malaria and advancing universal health coverage are key elements of the memorandum

The World Health Organization and the International Organisation of the Francophonie (IOF) today signed a memorandum of understanding to scale up collaboration and boost access to health services in Francophone countries. The agreement, finalized at a ceremony held at the WHO Headquarters in Geneva, focuses on advancing universal health coverage, fighting…

Source: World Health Organization (WHO) |

Interim statement of the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety on AstraZeneca COVID-19 vaccine, 7 April 2021

Events under assessment are very rare, with low numbers reported among the almost 200 million individuals who have received the AstraZeneca COVID-19 vaccine

The COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) has reviewed reports of rare cases of blood clots with low platelets following vaccination with the AstraZeneca COVID-19 vaccine (including Covishield) since their onset a few weeks ago. At its most recent meeting on 7 April, 2021,…

Source: World Health Organization (WHO) |

WHO urges countries to build a fairer, healthier world post-COVID-19

As countries move forward post-COVID-19, it will be vital to avoid cuts in public spending on health and other social sectors

COVID-19 has unfairly impacted some people more harshly than others, exacerbating existing inequities in health and welfare within and between countries. For World Health Day, 7 April 2021, WHO is therefore issuing five calls for urgent action to improve health for all people. Within countries, illness and death from COVID-19 have been…

Source: World Health Organization (WHO) |

Tunisia receives first batch of COVID-19 vaccines through COVAX Facility

The COVAX Initiative also provided the Ministry of Health with a set of 506,400 syringes and 1,100 safety boxes

Tunisia received today the first batch of 93,600 doses of Pfizer COVID-19 vaccines through the COVAX Facility. This delivery is part of a first wave of arrivals that will continue during the year, with the goal of vaccinating 20% ​​of the population in Tunisia. “This shipment represents an important step…

Source: World Health Organization (WHO) |

Coronavirus - Ghana: COVID-19 vaccine doses shipped by the COVAX Facility head to Ghana, marking beginning of global rollout

Ghana became the first country outside India to receive COVID-19 vaccine doses shipped via the COVAX Facility

COVAX announces 600,000 doses of the AstraZeneca/Oxford vaccine licensed to Serum Institute of India have arrived in Accra, Ghana; further deliveries to Abidjan, Cote d’Ivoire are expected this week; Final first round of allocations for doses of AstraZeneca/Oxford and Pfizer-BioNTech vaccines, to the majority of countries and economies participating in the COVAX Facility,…

Source: World Health Organization (WHO) |

Coronavirus - The Oxford/AstraZeneca COVID-19 vaccine: what you need to know

Vaccination is recommended for persons with comorbidities that have been identified as increasing the risk of severe COVID-19

The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim recommendations for use of the Oxford/AstraZeneca COVID-19 vaccine (AZD1222).  Here’s a brief summary; you may access the guidance document here.  Who should be vaccinated first? While vaccine supplies are limited, it is recommended that priority be given…

Source: World Health Organization (WHO) |

Coronavirus: COVAX announces new agreement, plans for first deliveries

COVAX announced that, pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford candidate are anticipated to be available in Q1 2021

COVAX announced the signing of an advance purchase agreement for up to 40 million doses of the Pfizer-BioNTech vaccine; rollout to commence with successful execution of supply agreements; additionally, COVAX announced that, pending WHO emergency use listings, nearly 150 million doses of the AstraZeneca/Oxford candidate are anticipated to be available…

Source: World Health Organization (WHO) |

Emergency Committee on COVID-19 advises on variants, vaccines

The committee urged WHO to develop a standardized system for naming new variants that avoids geographical markers, an area WHO has already begun work on

The COVID-19 pandemic continues to constitute a Public Health Emergency of International Concern (PHEIC), according to the WHO Emergency Committee (EC) on COVID-19. The EC met virtually yesterday (14 January) at the request of WHO Director-General Dr Tedros Adhanom Ghebreyesus to review the emerging variants of SARS-CoV-2, the virus that…

Source: World Health Organization (WHO) |

WHO calls for reinvigorated action to fight malaria

Global malaria gains threatened by access gaps, COVID-19 and funding shortfalls

The World Health Organization (WHO) is calling on countries and global health partners to step up the fight against malaria, a preventable and treatable disease that continues to claim hundreds of thousands of lives each year. A better targeting of interventions, new tools and increased funding are needed to change…

Source: World Health Organization (WHO) |

11th Ebola outbreak in the Democratic Republic of the Congo declared over

The outbreak took place in communities scattered across dense rain forests as well as crowded urban areas, creating logistical challenges

Today marks the end of the 11th Ebola outbreak in the Democratic Republic of the Congo (DRC), nearly six months after the first cases were reported in Equateur Province. The outbreak took place in communities scattered across dense rain forests as well as crowded urban areas, creating logistical challenges. These…